It moves to the text on this page.
  • Contact Us
  • Site Map
Text Size
Small
Large

Eisai Ltd.

  • About Eisai
    • Message from the President
    • Corporate Information
    • Factory
  • Corporate Mission
    • Corporate Philosophy
    • What is hhc?
    • Our Policy
    • Compliance Activities
  • Healthcare
    • Disease
    • OTC and Cosmetic
    • Healthcare Professionals Only
  • Career

The local navigation starts here.

News Release

  • History
  • Communication Office
  • News Release
    • Local News

Home  >  About Us  >  Corporate  >  News release

The text starts here.

News Release

PT Eisai Indonesia  archive of new release list.

  • 2016
  • 2015
  • 2013

2016 Release

October, 2016 [International] CEO Haruo Naito, Top 100 Best-Performing CEOs in the World
September, 2016 [International] EISAI SELECTED FOR FOURTH CONSECUTIVE YEAR OF MEMBERSHIP IN DOW JONES SUSTAINABILITY ASIA PACIFIC INDEX 2016
August, 2016 [International] EISAI TO LAUNCH CHOCOLA BB® MOUTH ULCER REPAIR SHOT
August, 2016 [International] U.S. FDA CONFIRMS SUFFICIENT DATA TO ADVANCE INVESTIGATIONAL BACE INHIBITOR E2609 FOR TREATMENT OF EARLY ALZHEIMER'S DISEASE TO PHASE III
June, 2016 [International] EISAI LISTED FOR 15TH CONSECUTIVE YEAR IN FTSE4GOOD INDEX SERIES, AN INDEX FOR SOCIALLY RESPONSIBLE INVESTMENT
June, 2016 [Local] Vacancies at PT Eisai Indonesia
June, 2016 [International] Creating Leaflet for DEC Tablets in Local Languages for Endemic Countries
May, 2016 [Local] Eisai Indonesia Toll Manufacturing
April, 2016 [International] EISAI TO SUPPORT RELIEF EFFORTS FOR 2016 KUMAMOTO EARTHQUAKES

Back to Top

2015 Release

October, 2015 [International] EISAI TO PROVIDE DIETHYLCARBAMAZINE CITRATE TABLETS FREE OF CHARGE FOR USE IN NATIONAL LYMPHATIC FILARIASIS ELIMINATION CAMPAIGN IN INDONESIA
September, 2015[International] EISAI SELECTED FOR THIRD CONSECUTIVE YEAR OF MEMBERSHIP OF DOW JONES SUSTAINABILITY ASIA PACIFIC INDEX 2015
September, 2015 [International] EISAI TO PRESENT LATEST CLINICAL DATA ON LENVIMA® (LENVATINIB) AND HALAVEN® (ERIBULIN) AT EUROPEAN CANCER CONGRESS
September, 2015[International] Drugs for Neglected Diseases initiative and Eisai Co., Ltd. to Test Drug Candidate for Eumycetoma
September, 2015 [International] LAUNCH OF NEW KL-6 DIAGNOSTIC KIT HISCL KL-6, FOR DETECTING MARKER FOR INTERSTITIAL PNEUMONIA WITH HISCL AUTOMATED IMMUNOASSAY SYSTEMS
August 5, 2015 EISAI LISTED FOR 14TH CONSECUTIVE YEAR IN FTSE4GOOD INDEX SERIES, AN INDEX FOR SOCIALLY RESPONSIBLE INVESTMENT
July, 2015 [International] Eisai submits new drug application in Japan for in-house-discovered antiepileptic drug PERAMPANEL as adjunctive therapy for partial-onset and generalized tonic-clonic seizures
June, 2015 [Local] Internship abroad - Eisai project partnership with AIESEC

Back to Top

2013 Release

November, 2013 [Local] Supporting LF Elimination Program in Indonesia
September, 2013 [Local] Celebration of the World Alzheimer’s Month
September, 2013 [Local] PT Eisai Indonesia Commemorates World Alzheimer Month
March, 2013 [Local] Brandt Daroff Exercises for Vertigo Patient
February, 2013 [Local] PT Eisai Indonesia conduct community session for elder
January, 2013 [Local] PT Eisai Indonesia conduct HHC program : Senam Latih Otak at GBK

Back to Top


human health care

  • Eisai Global
  • Contact Us
  • Site Map

Copyright (C) Eisai Co., Ltd. All Rights Reserved.

Back to Top

  • Privacy Policy
  • Terms of Use
  • Accessibility